The Truth About 'Good Enough' in Medical Devices
After four years reviewing quality specs for a major device manufacturer – roughly 200+ product batches annually – I’ve come to a conclusion that might ruffle some feathers: what counted as “good enough” in 2020 is now a compliance risk. Not a minor gap. A real, auditable, patient-safety risk.
That’s not hyperbole. I’ve seen it firsthand.
My Perspective – And Why It Matters
I’m a quality compliance manager at a company that makes critical-care devices – infusion pumps, airway management kits, vascular access sets. I reject roughly 8% of first-time deliveries. In Q1 2024 alone, I flagged 12 batches for spec deviations that would have passed our internal tests five years ago. Things like outer package seal integrity and label adhesive performance – details that seem small until they cause a sterile barrier breach during transport.
Here’s what I think: the medical device industry is evolving under our noses, and most hospitals haven’t updated their vendor evaluation frameworks.
Why the Old Playbook Doesn’t Work Anymore
1. Technology Changed the Baseline
Take infusion pumps. In 2019, a pump that delivered ±5% accuracy was considered clinical grade. Today, with smart pumps that communicate with EHRs and dose-error reduction software, the tolerance has narrowed to ±2% – and that’s becoming the de facto standard in many ICUs. (I learned this the hard way when a batch of older-design pumps failed a hospital’s new acceptance test in early 2023.)
It’s not just pumps. Medical imaging, autoclave cycles, shockwave therapy devices – every segment has a tighter spec now. The question is whether your quality checklist has kept up.
2. Regulatory Pressure Is Real
FDA’s transition to the Quality Management System Regulation (QMSR) in 2024 brought ISO 13485:2016 into the enforcement spotlight. That means annual supplier audits now dig into process validation, not just product testing. A vendor who passed your paper audit last year might fail a site visit this year. (We rejected a long-time supplier for incomplete sterilization validation records in Q4 2024 – cost us $18,000 in rework, but saved a potential recall.)
3. End-User Expectations Have Shifted
Hospitals aren’t the only ones demanding more. Veterinary clinics too. When a veterinary hospital started using our syringe pumps for large-animal anesthesia, they asked for dosing accuracy data that went beyond our standard specification. That caught us off guard – but it’s a sign of the times. Even non-human medical settings are adopting human-grade thresholds.
The One Argument I Hear Most – And Why It’s Half True
“But our existing devices are working fine. Why change?”
I get it. I’ve said that myself. And it’s true that many older devices still perform adequately. But the risk isn’t in the device that’s already in the field – it’s in the next batch you order. If your procurement spec hasn’t been updated in three years, you’re buying yesterday’s risk.
Take a recent example: we sourced a batch of tracheostomy tubes for a long-term contract. The spec said “sterile, single-use, non-pyrogenic.” That’s what we ordered. But the manufacturer had quietly switched their sterilization method from ethylene oxide (EO) to radiation without notifying us. The tubes were sterile, technically, but the packaging material wasn’t validated for the new method. Eight hundred units showed up with compromised seals. We rejected the entire lot. (Took three weeks to re-manufacture. The clinical team was furious.)
That kind of supply chain drift happens constantly. And unless you’re auditing the process – not just the certificate – you won’t catch it.
What This Means for Your Next Vendor Review
I’m not saying every hospital needs to become a QA lab. But I am saying:
- Update your supplier questionnaire to include questions about latest regulatory transitions (e.g., FDA QMSR, MDR, MDSAP).
- Ask for process validation records, not just product test results.
- Build time into your contract for batch sampling – and actually do it (note to self: we need a better protocol for this).
Does this add friction? Yes. But the alternative – discovering a quality gap during a JCAHO audit or, worse, a patient event – is far more expensive.
Final Thought: The Industry Moves, But Not Always Forward
I’ve been wrong before. In 2022, I pushed for a new supplier based on their glossy FDA certificate. Turns out their internal QMS was a mess (the certificate was from a pre-acquisition entity that had lapsed). I second-guessed that decision for months. It was a costly lesson. (Approved the change order; immediately worried I’d made the wrong call.)
So, no, evolution isn’t always linear. Sometimes standards regress before they improve. But the trend is clear: staying with the same specifications, same approval process, same vendor expectations means falling behind – quietly, but definitely.
If you manage a hospital procurement or quality team, take a hard look at your device acceptance criteria. Ask yourself: when was the last time you challenged them? If the answer is “more than two years ago,” you might be overdue.
That’s my take. I’m curious what others have seen – especially in imaging, autoclave, or shockwave therapy, where I’m less familiar with the nuances. (Honestly, I don’t know the latest spec changes in those areas. If someone has insight, I’d love to hear it.)
Context: This perspective comes from a mid-size device manufacturer dealing mostly with US hospitals. If you’re in a rural clinic or overseas market, the picture might look different. Your mileage may vary.
